Tel Aviv - Delayed Quote • ILA
Compare
As of 2:46 PM GMT+3. Market Open.
Line
Candle
Baseline
Mountain
Bar
Loading Chart for TEVA.TA
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
6,131.00 - Open
6,200.00 - Bid 6,212.00 x 200
- Ask 6,214.00 x 34100
- Day's Range
6,199.00 - 6,250.00 - 52 Week Range
2,786.00 - 6,494.00 - Volume
396,119 - Avg. Volume
1,477,562 - Market Cap (intraday)
70.394B - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
-- - EPS (TTM)
-1.58 - Earnings Date Jul 31, 2024 - Aug 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Nov 28, 2017
- 1y Target Est
14.86
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
35,001
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Industry
More about Teva Pharmaceutical Industries Limited
Recent News: TEVA.TA
View MoreAll SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: TEVA.TA
Trailing total returns as of 7/3/2024, which may include dividends or other distributions. Benchmark is TA-125
YTD Return
TEVA.TA
61.85%
TA-125
4.47%
1-Year Return
TEVA.TA
121.10%
TA-125
9.32%
3-Year Return
TEVA.TA
90.64%
TA-125
11.02%
5-Year Return
TEVA.TA
85.63%
TA-125
32.13%
Compare To: TEVA.TA
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
6,215.00
+1.37%
Mkt Cap ILA 70.394B
Industry Drug Manufacturers—Specialty & Generic
779.00
+2.18%
Mkt Cap ILA 359.392M
Industry Drug Manufacturers—Specialty & Generic
2.0500
+0.99%
Mkt Cap 93.424M
Industry Drug Manufacturers—Specialty & Generic
12.24
-0.97%
Mkt Cap 3.696B
Industry Drug Manufacturers—Specialty & Generic
0.8400
-5.83%
Mkt Cap 4.275M
Industry Drug Manufacturers—Specialty & Generic
2,266.00
0.00%
Mkt Cap JPY 34.654B
Industry Drug Manufacturers—Specialty & Generic
1,620.00
-0.18%
Mkt Cap JPY 5.846B
Industry Drug Manufacturers—Specialty & Generic
15.68
0.00%
Mkt Cap PLN 800.566M
Industry Drug Manufacturers—Specialty & Generic
2,463.00
-0.48%
Mkt Cap JPY 69.775B
Industry Drug Manufacturers—Specialty & Generic
3,020.00
+0.97%
Mkt Cap JPY 148.645B
Industry Drug Manufacturers—Specialty & Generic
514.90
+1.82%
Mkt Cap ILA 45.236M
Industry Drug Manufacturers—Specialty & Generic
Statistics: TEVA.TA
View More
Valuation Measures
As of 7/2/2024
Market Cap
69.44B
Enterprise Value
133.22B
Trailing P/E
--
Forward P/E
8.60
PEG Ratio (5yr expected)
1.22
Price/Sales (ttm)
1.14
Price/Book (mrq)
2.54
Enterprise Value/Revenue
2.21
Enterprise Value/EBITDA
26.80
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.99%
Return on Assets (ttm)
4.84%
Return on Equity (ttm)
-9.67%
Revenue (ttm)
16B
Net Income Avi to Common (ttm)
-478M
Diluted EPS (ttm)
-1.58
Balance Sheet and Cash Flow
Total Cash (mrq)
2.99B
Total Debt/Equity (mrq)
264.33%
Levered Free Cash Flow (ttm)
3.57B
Research Analysis: TEVA.TA
View MoreCompany Insights: TEVA.TA
Research Reports: TEVA.TA
View MorePeople Also Watch
BEZQ.TA Bezeq The Israel Telecommunication Corp. Ltd
439.80
+0.94%
ELAL.TA El Al Israel Airlines Ltd.
459.40
+1.66%
ESLT.TA Elbit Systems Ltd.
69,240.00
+1.07%
LUMI.TA Bank Leumi le-Israel B.M.
3,099.00
+0.49%
TSEM.TA Tower Semiconductor Ltd.
14,780.00
-1.40%
DLEKG.TA Delek Group Ltd.
41,060.00
+3.79%
POLI.TA Bank Hapoalim B.M.
3,366.00
-0.03%
NICE.TA NICE Ltd.
63,150.00
-1.13%
ICL.TA ICL Group Ltd
1,587.00
+0.13%
DSCT.TA Israel Discount Bank Limited
1,906.00
-0.47%
MZTF.TA Mizrahi Tefahot Bank Ltd.
13,040.00
+0.23%
FTAL.TA Fattal Holdings (1998) Ltd
39,440.00
+3.52%
SAE.TA Shufersal Ltd
2,475.00
-0.12%
OPK.TA OPKO Health, Inc.
454.80
-1.07%
AZRG.TA Azrieli Group Ltd.
22,320.00
+0.31%
KMDA.TA Kamada Ltd.
2,015.00
+8.08%